AnalystBook Research · Company Intelligence

Anheuser-Busch InBev SA/NV

BUDNYSE

Built from Anheuser-Busch InBev SA/NV's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Reported revenue slipped 0.7% to $59.32B as volumes fell 3.0% and currencies cost $1.3 billion, but pricing held the operating margin at 26.0% and net income rose 16.8%.

The read at a glance✓ Audited against SEC data
  • Growth — Revenue -0.7% to $59.32B; volumes -3.0%Watch
  • Profitability — Operating margin 26.0%, flat; net income +16.8% to $6.84BOK
  • Cash — Free cash flow $11.23B, +0.3%OK
  • Accounting — Altman-Z in the distress zone; no manipulation flag; earnings quality safeWatch
  • Capital — Dividends +34.9% to $4.29BOK
  • Debt — Net debt $60.9 billionWatch

Business

Anheuser-Busch InBev describes itself as the world's largest brewer by volume, with well over 400 beer and other brands, including Corona, Stella Artois and Michelob ULTRA globally and Bud Light, Modelo Especial, Skol and Brahma locally. Its shares trade on Euronext Brussels and its ADSs on the NYSE. It reports in US dollars.

Latest filings

  • 6-K · Company announcement (foreign filer)2026-07-30
  • 6-K · Company announcement (foreign filer)2026-07-30
  • 6-K · Company announcement (foreign filer)2026-06-16
  • 6-K · Company announcement (foreign filer)2026-05-14
  • 6-K · Company announcement (foreign filer)2026-05-05
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Anheuser-Busch InBev SA/NV, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.